Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael L Hutton

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Expert Opinion on Therapeutic Targets|March 22, 2007
Microtubule-associated protein tau as a therapeutic target in neurodegenerative diseaseHanno M Roder, Michael L Hutton
Brain Pathology (Zurich, Switzerland)|May 12, 2007
Progressive supranuclear palsy: pathology and geneticsDennis W Dickson, Rosa Rademakers, Michael L Hutton
Journal of Neuroinflammation|February 13, 2007
Progranulin in frontotemporal lobar degeneration and neuroinflammationZeshan Ahmed, Ian R A Mackenzie, Michael L Hutton, et al.
Neuroscience Letters|October 3, 2006
Neurofibrillary tangle-related synaptic alterations of spinal motor neurons of P301L tau transgenic miceOmi Katsuse, Wen-Lang Lin, Jada Lewis, et al.
Mayo Clinic Proceedings|May 13, 2005
Heredofamilial brain calcinosis syndromeYasuhiko Baba, Daniel F Broderick, Ryan J Uitti, et al.
Brain Research. Molecular Brain Research|May 26, 2005
Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregatesIrving E Vega, Li Cui, Josh A Propst, et al.
Acta Neuropathologica|August 15, 2014
Anti-Aβ antibody target engagement: commentary regarding Watt et al. Acta Neuropathol 127:803-810 (2014)Eric Siemers, Robert A Dean, Ronald B DeMattos, et al.
Alzheimer Disease and Associated Disorders|June 27, 2008
Early onset familial Alzheimer Disease with spastic paraparesis, dysarthria, and seizures and N135S mutation in PSEN1Leslie A Rudzinski, Rita M Fletcher, Dennis W Dickson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 19, 2009
Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrig's disease in rats via TDP-43 overexpressionJason B Tatom, David B Wang, Robert D Dayton, et al.
BMC Neurology|April 18, 2008
APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central NorwaySigrid B Sando, Stacey Melquist, Ashley Cannon, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Expert Opinion on Therapeutic Targets|March 22, 2007
Microtubule-associated protein tau as a therapeutic target in neurodegenerative diseaseHanno M Roder, Michael L Hutton
Brain Pathology (Zurich, Switzerland)|May 12, 2007
Progressive supranuclear palsy: pathology and geneticsDennis W Dickson, Rosa Rademakers, Michael L Hutton
Journal of Neuroinflammation|February 13, 2007
Progranulin in frontotemporal lobar degeneration and neuroinflammationZeshan Ahmed, Ian R A Mackenzie, Michael L Hutton, et al.
Neuroscience Letters|October 3, 2006
Neurofibrillary tangle-related synaptic alterations of spinal motor neurons of P301L tau transgenic miceOmi Katsuse, Wen-Lang Lin, Jada Lewis, et al.
Mayo Clinic Proceedings|May 13, 2005
Heredofamilial brain calcinosis syndromeYasuhiko Baba, Daniel F Broderick, Ryan J Uitti, et al.
Brain Research. Molecular Brain Research|May 26, 2005
Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregatesIrving E Vega, Li Cui, Josh A Propst, et al.
Acta Neuropathologica|August 15, 2014
Anti-Aβ antibody target engagement: commentary regarding Watt et al. Acta Neuropathol 127:803-810 (2014)Eric Siemers, Robert A Dean, Ronald B DeMattos, et al.
Alzheimer Disease and Associated Disorders|June 27, 2008
Early onset familial Alzheimer Disease with spastic paraparesis, dysarthria, and seizures and N135S mutation in PSEN1Leslie A Rudzinski, Rita M Fletcher, Dennis W Dickson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 19, 2009
Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrig's disease in rats via TDP-43 overexpressionJason B Tatom, David B Wang, Robert D Dayton, et al.
BMC Neurology|April 18, 2008
APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central NorwaySigrid B Sando, Stacey Melquist, Ashley Cannon, et al.
Pageof 5